Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone in Symptomatic IBD
NCT01810185Phase 2Withdrawn
- Sponsor
- Santa Barbara Cottage Hospital
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis (UC), sponsored by Santa Barbara Cottage Hospital. Planned start Mar 2013; status: withdrawn.
02
Drugs
naltrexone
03
Conditions
inflammatory bowel disease (IBD)Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01810185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810185.